Biennial eye screening in patients with diabetes without retinopathy: 10-year experience

@article{lafsdttir2007BiennialES,
  title={Biennial eye screening in patients with diabetes without retinopathy: 10-year experience},
  author={Eyd{\'i}s {\'O}lafsd{\'o}ttir and Einar Stef{\'a}nsson},
  journal={British Journal of Ophthalmology},
  year={2007},
  volume={91},
  pages={1599 - 1601}
}
Aims: To evaluate the safety of every-other-year eye screening for patients with diabetes without retinopathy. Methods: Since 1994, patients with diabetes without retinopathy in Iceland have received eye screening every other year. 296 patients with diabetes who had no diabetic retinopathy in 1994/95 were followed with biennial eye examinations until they had developed retinopathy. The 10-year experience of this approach is reviewed. Results: Out of the 296 diabetic individuals, 172 did not… 

Screening for Diabetic Retinopathy and Diabetic Macular Edema in the United Kingdom

TLDR
The current situation of diabetic retinopathy screening in the UK is summarized, the challenges ahead are outlined and internal and external quality assurance ensures efficacy and safety.

Determining diabetic retinopathy screening interval based on time from no retinopathy to laser therapy

TLDR
Patients who attend for retinal screening and treatment who have no or non-proliferative retinopathy now have a very low risk of eventual blindness from diabetes.

Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy

TLDR
In this longitudinal ophthalmologic registry population involving eyes with good vision, more advanced DR at first diagnosis was a significant risk factor for developing sustained blindness.

Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals

TLDR
It may be possible to stratify patients for risk, according to baseline retinal criteria, into groups with low and high risk of their conditions progressing to proliferative retinopathy, and screening intervals for such diverse groups of patients could safely be modified according to their risk.

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

TLDR
The analysis supports the extension of the screening interval for people with type 2 diabetes mellitus beyond the currently recommended 12 months, with the possible exception of those with diabetes duration of 10 years or more and on insulin treatment.

Diabetic retinopathy screening: global and local perspective.

TLDR
Different methods of screening including grading used to detect the severity of sight-threatening retinopathy and the newer screening methods are reviewed, including the method of systematic screening being carried out in Hong Kong.

Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review

TLDR
The overall tendency observed in these programmes was that 2‐year screening intervals among people with no diabetic retinopathy at diagnosis were not associated with high incidence of sight‐threatening diabetic Retinopathy, and a shorter interval ≤1 year is warranted.

Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy?

TLDR
The simulation model predicts that implementing a 2-year screening interval for type 2 diabetic patients without evidence of diabetic retinopathy does not increase their risk of vision loss and could reduce screening costs by ∼25%.

Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study

TLDR
Patients who do not attend diabetic eye screening are at increased risk of developing STDR, and tracing of non-attenders with evidence of established retinopathy should be an important fail-safe procedure.
...

References

SHOWING 1-10 OF 20 REFERENCES

Active prevention in diabetic eye disease. A 4-year follow-up.

TLDR
The incidence of retinopathy in Icelandic type 1 diabetics participating in the annual eye screening program is low and the visual acuity stable, and the results suggest that visual impairment in diabetICS can be prevented with active regular screening and standard laser therapy.

Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.

TLDR
The results indicated that diabetic children under the age of 12 do not need regular screening for eye disease and ways to make the screening program more efficient by identifying subgroups at low risk for developing eye disease that required treatment and therefore needed less frequent screening were examined.

Screening for eye disease in type 2 diabetes mellitus

TLDR
This report reports on 245 diabetic patients with type 2 diabetes in Iceland who had visual acuity equal or better than 6/12 in their better eye, and 24 of them had clinically significant diabetic macular edema.

A small number of older type 2 diabetic patients end up visually impaired despite regular photographic screening and laser treatment for diabetic retinopathy.

TLDR
A small number of older type 2 diabetic patients end up with visual impairment due to unsuccessful photocoagulation of macular oedema, and the only independent risk factor for visual impairment in eyes with sight-threatening retinopathy was age.

Screening and prevention of diabetic blindness.

TLDR
The organisation and methods of screening programs for diabetic eye disease screening programs are described including direct and photographic screening and technical advantages may allow increased efficiency and telescreening.

Screening for diabetic retinopathy

TLDR
It is indicated that diabetic children under the age of 12 years do not need regular screening for eye disease and biannual examinations seem to suffice in type 1 and 2 diabetic patients without retinopathy.

Screening for diabetic retinopathy. Initiation and frequency.

TLDR
It is indicated that diabetic children under the age of 12 years do not need regular screening for eye disease and biannual examinations seem to suffice in type 1 and 2 diabetic patients without retinopathy.

Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme.

TLDR
Multivariate analysis showed a statistically significant association between blindness/visual impairment and old age, long duration of diabetes, and poor glycaemic control, which may be of value for the prevention of visual loss.

The occurrence and causes of registered blindness in diabetes patients in Arhus County, Denmark.

TLDR
The major challenge in reducing diabetes-related blindness is related to the detection and treatment of an increased incidence of diabetic maculopathy in type 2 diabetes patients.